Posted by Michael Wonder on 25 Nov 2021
MSAC publishes agenda for upcoming meeting
24 November 2021 - 10 agenda items for consideration at the 31 March - 1 April 2022 meeting.
The assessments of note are:
- Whole genome sequencing of antimicrobial-resistant pathogens (1646)
- KRAS G12C variant testing to determine eligibility for PBS subsidised sotorasib for the second-line treatment of patients with locally advanced or metastatic non small-cell lung cancer (1669)
- Procedures for the implantation and refill-exchange of the port delivery system with ranibizumab to treat patients with neovascular age-related macular degeneration (1695)
